GlucoFriend-evaluation the effectiveness of Glucobay when combined with a basal insulin
To evaluate the effectiveness of Glucobay when combined with a basal insulin under daily-life treatment conditions in a large sample of Korean patients.
- Signed written informed consent - Age ≥ 18 years - Diagnosed of type 2 diabetes for at least 6 months prior to enrollment - Patients treated with stable dose of a basal insulin (insulin glargine or insulin detemir) at least 2 months - HbA1C≥7.5 and ≤10.0%
- Exclusion criteria must be read in conjunction with the local product information
Many Locations, South Korea
E-mail: [email protected]
Phone: Not Available
Combined use of a basal insulin and Glucobay For reducing PPG to end diabetes progress